Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders (Q45292482)

11 December 2017

Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders (English)

1 reference

https://api.crossref.org/works/10.1038/JCBFM.1991.53

single-photon emission computed tomography

25 October 2022

main subject

dopamine

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671782

Cardiology and cardiovascular medicine

25 October 2022

1 reference

https://api.crossref.org/works/10.1038/JCBFM.1991.53

25 October 2022

1 reference

https://api.crossref.org/works/10.1038/JCBFM.1991.53

25 October 2022

author name string

T. Brücke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671782

25 October 2022

I. Podreka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671782

25 October 2022

P. Angelberger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671782

25 October 2022

S. Wenger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671782

25 October 2022

A. Topitz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671782

25 October 2022

B. Küfferle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671782

25 October 2022

C. Müller

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671782

25 October 2022

L. Deecke

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671782

25 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1671782

25 October 2022

publication date

1 March 1991

1 reference

full work available at URL

11 December 2017

http://journals.sagepub.com/doi/pdf/10.1038/jcbfm.1991.53

1 reference

https://api.crossref.org/works/10.1038/JCBFM.1991.53

Journal of Cerebral Blood Flow & Metabolism

25 October 2022

published in

1 reference

11 December 2017

11

1 reference

11 December 2017

220-228

1 reference

11 December 2017

2

1 reference

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

11 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

In vivo assay for neuroleptic receptor binding in the striatum. Positron tomography in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Dopamine D-1 and D-2 receptors in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Dopamine D2 receptor density remains constant in treated Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

76Br-bromospiroperidol: A new tool for quantitative in-vivo imaging of neuroleptic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Imaging dopamine receptors in the human brain by positron tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

7 January 2021

Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

7 January 2021

Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

7 January 2021

Divergent changes in D-1 and D-2 dopamine binding sites in human brain during aging

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

7 January 2021

Quantification of regional cerebral blood flow with IMP-SPECT. Reproducibility and clinical relevance of flow values

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

7 January 2021

Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

7 January 2021

Dopamine receptor occupancy and plasma haloperidol levels

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1991.53

7 January 2021

Identifiers

1 reference

11 December 2017

1 reference